View drug registration information details.
Items | Registration information |
ID | 369 |
No | 369 |
Brand Name | V-GAVIR 450 |
Ingredients | VALGANCICLOVIR HCL USP EQ.TO VALGANCICLOVIR 450 MG |
Dosage Form | FILM-COATED TABLETS |
Primary Packaging | ALU-STRIP |
Storage | STORE AT 25 C, PROTECT FROM MOISTURE |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 5 X 4'S |
Dispensing Category | Prescription only |
ATC Classification | J05AB14 |
Pharmaceutical Class | ANTIVIRAL |
Indications | FOR THE INDUCTION AND MAINTENANCE TREATMENT OF CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME, FOR THE PREVENTION OF CMV DISEASE IN CMV-NEGATIVE PATIENTS WHO HAVE RECEIVED A SOLID ORGAN TRANSPLANT FROM A CMV-POSITIVE DONOR |
Contraindications | HYPERSENSITIVITY, IN PATIENTS WITH HYPERSENSITIVITY TO ACICLOVIR AND VALACICLOVIR, DURING BREAST-FEEDING |
Side Effects | NEUTROPENIA, ANEMIA, DIARRHEA, |
Unit Price | 15.2 |
EDL |
No |
Description | DARK BROWN COLOURED, CAPSULE SHAPED BICONVEX, FILM COATED TABLETS |
Note | |
License Owner | CBF PHARMA CO.,LTD |
Manufacturer | UNITED BIOTECH (P) LIMITED |
Country | INDIA |
Import Registration No | MNB/05/254 |
Import Registration Date | 2016-02-23 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2023-05-05 |
FDD Registration No | 06 I 4943/20 |
FDD Registration Date | 2023-08-14 |
Expiry Date | 2026-08-13 |
Back to drug list
|